News

Astellas Pharma Canada has reported encouraging results from a Canadian study which showed that patients with overactive bladder treated with solifenacin reported significantly lower incidence and severity of

The company has reported total revenues of $519.97 million for the first quarter of 2009 compared to $443.22 million for the first quarter of 2008. Frank Baldino Jr,

The first force-sensing ablation catheter developed worldwide, TactiCath gives physicians a real-time, objective measure of contact force during the catheter ablation procedure, said Endosense. The CE Mark allows

As part of the agreement, Ergomed will advance the oral formulation of tasidotin, developed by Genzyme, into clinical trials. In an earlier Phase II clinical trial sponsored by

By promoting the development, coordination and sharing of research resources and expertise, these awards expand research opportunities and increase the number of competitive investigators in 23 eligible states

Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, has reported that it is conducting a voluntary recall of all lots of Nitrofurantoin capsules, USP 100mg currently on

Allergan, a multi-specialty healthcare company, has reported net earnings of $45m for the first quarter of 2009, compared to $107.9m for the first quarter of 2008. Allergan has

Net sales for the first quarter increased 22% to $3.15 billion, compared to $2.57 billion in the first quarter of 2008. The acquisition of Barr contributed to the

Mr Zhou’s responsibilities in his new role include financial planning and analysis, ERP system implementation, tax, and treasury. Prior to joining WuXi PharmaTech, Mr Zhou worked for 11